Generate a tailored SOP for Dr. Gregory Knipp. Improve your application with a focused, well-structured draft.
Gregory T. Knipp is a Professor in the College of Pharmacy at Purdue University, specializing in preclinical drug discovery support, with notable expertise in ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) and the Blood-Brain Barrier. He holds a Bachelor of Science degree in Biochemistry from Cook College, Rutgers, a Master of Science in Pharmaceutical Chemistry from the University of Kansas, and a Ph.D. in Pharmaceutical Chemistry from the same institution. Knipp's research focuses on developing novel in vitro and in vivo models for assessing pharmaceutical performance. His laboratory emphasizes blood-brain barrier permeability linked to neuroactivity and engages in pharmacokinetic studies for novel drug formulations. Knipp has received significant grants for his research from the Department of Defense and the Environmental Protection Agency, investigating innovative treatments for various conditions including hydrocephalus and filovirus infections. Furthermore, he has been involved with several NIH funded projects aimed at creating cyanide countermeasures. Greg also serves as the faculty director of the Purdue Translational Pharmacology CTSI Core Facility, underscoring his dedication to bridging the gap between preclinical research and clinical application. He actively teaches courses on industrial practical training and advanced biopharmaceutics, contributing to the educational development of future professionals in the pharmaceutical sciences.
Purdue University • West Lafayette, IN
Research and teaching in pharmaceutical sciences, with a focus on drug discovery and development.
GRE scores (General and Subject) are NOT considered.